{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:19:36Z","timestamp":1791289176795,"version":"4.3.0"},"reference-count":39,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Animals"],"abstract":"<jats:p>Although antimicrobial resistance is an increasing threat in equine medicine, molecular and epidemiological data remain limited in North America. We assessed the prevalence of, and risk factors for, shedding multidrug-resistant (MDR) and extended-spectrum \u03b2-lactamase (ESBL) and\/or AmpC \u03b2-lactamase-producing E. coli in healthy horses in Quebec, Canada. We collected fecal samples in 225 healthy adult horses from 32 premises. A questionnaire on facility management and horse medical history was completed for each horse. Indicator (without enrichment) and specific (following enrichment with ceftriaxone) E. coli were isolated and tested for antimicrobial susceptibility. The presence of ESBL\/AmpC genes was determined by PCR. The prevalence of isolates that were non-susceptible to antimicrobials and to antimicrobial classes were estimated at the horse and the premises level. Multivariable logistic regression was used to assess potential risk factors for MDR and ESBL\/AmpC isolates. The shedding of MDR E. coli was detected in 46.3% of horses. Non-susceptibility was most commonly observed to ampicillin, amoxicillin\/clavulanic acid or streptomycin. ESBL\/AmpC producing isolates were detected in 7.3% of horses. The most commonly identified ESBL\/AmpC gene was blaCTX-M-1, although we also identified blaCMY-2. The number of staff and equestrian event participation were identified as risk factors for shedding MDR isolates. The prevalence of healthy horses harboring MDR or ESBL\/AmpC genes isolates in their intestinal microbiota is noteworthy. We identified risk factors which could help to develop guidelines to preclude their spread.<\/jats:p>","DOI":"10.3390\/ani10030523","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T11:42:11Z","timestamp":1584704531000},"page":"523","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Prevalence, Risk Factors, and Characterization of Multidrug Resistant and ESBL\/AmpC Producing Escherichia coli in Healthy Horses in Quebec, Canada, in 2015\u20132016"],"prefix":"10.3390","volume":"10","author":[{"given":"Maud","family":"de Lagarde","sequence":"first","affiliation":[{"name":"OIE Reference Laboratory for <i>Escherichia coli<\/i>, Faculty of Veterinary Medicine, Universit\u00e9 de Montr\u00e9al, Saint-Hyacinthe, QC J2S2M2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Fairbrother","sequence":"additional","affiliation":[{"name":"OIE Reference Laboratory for <i>Escherichia coli<\/i>, Faculty of Veterinary Medicine, Universit\u00e9 de Montr\u00e9al, Saint-Hyacinthe, QC J2S2M2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8382-7326","authenticated-orcid":false,"given":"Julie","family":"Arsenault","sequence":"additional","affiliation":[{"name":"Epidemiology of Zoonoses and Public Health Research Unit (GREZOSP), Faculty of Veterinary Medicine, Universit\u00e9 de Montr\u00e9al, Saint-Hyacinthe, QC J2S2M2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,3,20]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2014). Antimicrobial Resistance: Global Report on Surveillance, World Health Organization."},{"key":"ref_2","first-page":"213","article-title":"Drug resistance among pathogenic bacteria from animals in Ontario","volume":"38","author":"Hariharan","year":"1974","journal-title":"Can. J. Comp. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/eve.12837","article-title":"Infections caused by multidrug-resistant bacteria in an equine hospital (2012\u20132015)","volume":"31","author":"Schmitt","year":"2019","journal-title":"Equine Vet. Educ."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.2042-3292.2010.00071.x","article-title":"Multiple-drug resistant Acinetobacter baumannii bronchopneumonia in a colt following intensive care treatment","volume":"22","author":"Jokisalo","year":"2010","journal-title":"Equine Vet. Educ."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Giguere, S., Berghaus, L.J., and Willingham-Lane, J.M. (2017). Antimicrobial resistance in Rhodococcus equi. Microbiol. Spectr., 5.","DOI":"10.1128\/microbiolspec.ARBA-0004-2016"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2042-3306.2011.00441.x","article-title":"Cross-sectional study of antimicrobial-resistant bacteria in horses. Part 1: Prevalence of antimicrobial-resistant Escherichia coli and methicillin-resistant Staphylococcus aureus","volume":"44","author":"Maddox","year":"2012","journal-title":"Equine Vet. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/jvim.15415","article-title":"Prevalence, risk factors, and characterization of multidrug resistant and extended spectrum beta-lactamase\/AmpC beta-lactamase producing Escherichia coli in healthy horses in France in 2015","volume":"33","author":"Larrieu","year":"2019","journal-title":"J. Vet. Intern. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/mdr.2010.0036","article-title":"Evaluation of eight different cephalosporins for detection of cephalosporin resistance in Salmonella enterica and Escherichia coli","volume":"16","author":"Aarestrup","year":"2010","journal-title":"Microb. Drug Resist."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/evj.12471","article-title":"Antimicrobial resistance in bacteria from horses: Epidemiology of antimicrobial resistance","volume":"47","author":"Maddox","year":"2015","journal-title":"Equine Vet. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/104063870802000524","article-title":"Bronchopneumonia associated with extraintestinal pathogenic Escherichia coli in a horse","volume":"20","author":"DebRoy","year":"2008","journal-title":"J. Vet. Diagn. Investig."},{"key":"ref_11","unstructured":"Government of Canada (2016, September 01). Canadian Antimicrobial Resistance Surveillance Systeme\u2014Report, Available online: http:\/\/publications.gc.ca\/pub?id=9.512584&sl=1."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.vetmic.2014.01.017","article-title":"Extended-spectrum beta-lactamase, carbapenemase and AmpC producing Enterobacteriaceae in companion animals","volume":"170","author":"Rubin","year":"2014","journal-title":"Vet. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/vr.102708","article-title":"Trends in antimicrobial resistance in equine bacterial isolates: 1999\u20132012","volume":"176","author":"Johns","year":"2015","journal-title":"Vet. Rec."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1469-0691.2012.03850.x","article-title":"Extended-spectrum beta-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: A global perspective","volume":"18","author":"Ewers","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_15","first-page":"110","article-title":"CTX-M enzymes: Origin and diffusion","volume":"3","year":"2012","journal-title":"Front. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ijmm.2011.09.003","article-title":"Plasmids in Gram negatives: Molecular typing of resistance plasmids","volume":"301","author":"Carattoli","year":"2011","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1128\/CMR.00116-14","article-title":"The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae","volume":"28","author":"Mathers","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e00337-18","DOI":"10.1128\/mSphere.00337-18","article-title":"Escherichia coli sequence type 410 is causing new international high-risk clones","volume":"3","author":"Roer","year":"2018","journal-title":"mSphere"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"E256","DOI":"10.1111\/1469-0691.12150","article-title":"Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in humans living in municipalities with high and low broiler density","volume":"19","author":"Huijbers","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/jac\/dkv423","article-title":"Colonization and infection with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in ICU patients: What impact on outcomes and carbapenem exposure?","volume":"71","author":"Barbier","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_21","unstructured":"Health Canada (2009, April 01). Categorization of Antimicrobial Drugs Based on Importance in Human Medicine. Available online: https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/veterinary-drugs\/antimicrobial-resistance\/categorization-antimicrobial-drugs-based-importance-human-medicine.html."},{"key":"ref_22","unstructured":"World Health Organization (2017). Critically Important Antimicrobials for Human medicine: Ranking of Antimicrobial Agents for Risk Management of Antimicrobial Resistance due to Non-Human Use, World Health Organization."},{"key":"ref_23","unstructured":"Gouvernment of Quebec (2019). Decret 1110\u20132018. Loi sur la protection des animaux (chapitre P-42), Administration de Certains M\u00e9dicaments-Modification."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.2042-3306.2011.00440.x","article-title":"Cross-sectional study of antimicrobial-resistant bacteria in horses. Part 2: Risk factors for faecal carriage of antimicrobial-resistant Escherichia coli in horses","volume":"44","author":"Maddox","year":"2012","journal-title":"Equine Vet. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1128\/aem.59.7.2271-2276.1993","article-title":"Distribution of uidA gene sequences in Escherichia coli isolates in water sources and comparison with the expression of beta-glucuronidase activity in 4-methylumbelliferyl-beta-D-glucuronide media","volume":"59","author":"Martins","year":"1993","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/jac\/dkr507","article-title":"Prevalence of extended-spectrum cephalosporinase (ESC)-producing Escherichia coli in Danish slaughter pigs and retail meat identified by selective enrichment and association with cephalosporin usage","volume":"67","author":"Agerso","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Gigu\u00e8re, S., Prescott, J.F., and Dowling, P.M. (2013). Antimicrobial Therapy in Veterinary Medicine, John Wiley & Sons.","DOI":"10.1002\/9781118675014"},{"key":"ref_29","first-page":"1047","article-title":"Occurrence of antimicrobial resistant bacteria in healthy dogs and cats presented to private veterinary hospitals in southern Ontario: A preliminary study","volume":"50","author":"Murphy","year":"2009","journal-title":"Can. Vet. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.vetmic.2017.11.020","article-title":"Prevalence and mechanisms of extended-spectrum cephalosporin resistance in clinical and fecal Enterobacteriaceae isolates from dogs in Ontario, Canada","volume":"213","author":"Zhang","year":"2018","journal-title":"Vet. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1139\/cjm-2016-0504","article-title":"A survey of the antimicrobial susceptibility of Escherichia coli isolated from Sable Island horses","volume":"63","author":"Timonin","year":"2017","journal-title":"Can. J. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/jam.13166","article-title":"Circulating of CMY-2 beta-lactamase gene in weaned pigs and their environment in a commercial farm and the effect of feed supplementation with a clay mineral","volume":"121","author":"Jahanbakhsh","year":"2016","journal-title":"J. Appl. Microbiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e00037-19","DOI":"10.1128\/AEM.00037-19","article-title":"Effect of cessation of ceftiofur and substitution with lincomycin-spectinomycin on extended-spectrum-beta-lactamase\/AmpC genes and multidrug resistance in Escherichia coli from a Canadian broiler production pyramid","volume":"85","author":"Verrette","year":"2019","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_34","first-page":"137","article-title":"Occurrence and characterization of resistance to extended-spectrum cephalosporins mediated by beta-lactamase CMY-2 in Salmonella isolated from food-producing animals in Canada","volume":"66","author":"Allen","year":"2002","journal-title":"Can. J. Vet. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijantimicag.2010.02.016","article-title":"Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals","volume":"36","author":"Peirano","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_36","unstructured":"WHO (World Health Organisation) (2017, February 01). One Health. Available online: https:\/\/www.who.int\/features\/qa\/one-health\/en\/."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1086\/428052","article-title":"Mechanisms of resistance to quinolones","volume":"41","author":"Jacoby","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1198-743x.2001.00322.x","article-title":"Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992\u20131998","volume":"7","author":"Robert","year":"2001","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.fm.2012.04.017","article-title":"Phenotypic and genetic characterization of antimicrobial resistance in Salmonella serovars isolated from retail meats in Alberta, Canada","volume":"32","author":"Aslam","year":"2012","journal-title":"Food Microbiol."}],"container-title":["Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2615\/10\/3\/523\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:10:15Z","timestamp":1760173815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2615\/10\/3\/523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,20]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["ani10030523"],"URL":"https:\/\/doi.org\/10.3390\/ani10030523","relation":{},"ISSN":["2076-2615"],"issn-type":[{"value":"2076-2615","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,20]]}}}